⚠ FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION · QUALIFIED RESEARCHERS 21+
// PB-0036 Small Molecule Metabolic

SLU-PP-332

ERR agonist · small molecule.

SLU-PP-332 is a synthetic small-molecule agonist of the estrogen-related receptor (ERR) family, discovered at Saint Louis University. Recent research interest focuses on its reported exercise-mimetic effects via activation of mitochondrial biogenesis pathways. Supplied as research-grade material with 3rd-party HPLC verification and full Certificate of Analysis per lot.

01

Compound profile.

// CHEMICAL & STRUCTURAL SPEC — SLU-PP-332
MOLECULAR FORMULA
C21H27N3O3
Small Molecule · metabolic class.
MOLECULAR WEIGHT
369.5 Da
Monoisotopic / reported mass.
CLASS
Small Molecule
Compound classification.
ORIGIN
Synthetic · Saint Louis University
Source or discovery context.
STUDIED PATHWAYS
ERRα · ERRβ · ERRγ
Reported in published literature.
REPORTED HALF-LIFE
~12 hr (mice)
Oral bioavailable.
HPLC PURITY
99.8%
Minimum release spec · typical >99.9%.
APPEARANCE
White lyo.
White to off-white lyophilized form.
// PRIMARY STRUCTURE
N/A · small molecule

// SLU-PP-332 is a synthetic pan-agonist of all three estrogen-related receptor subtypes (ERRα, ERRβ, ERRγ). These nuclear receptors are orphan receptors (no known endogenous ligand) with roles in mitochondrial biogenesis and oxidative metabolism.
02

What the literature reports.

SLU-PP-332 is a synthetic small-molecule agonist of the estrogen-related receptor (ERR) family, discovered at Saint Louis University. Recent research interest focuses on its reported exercise-mimetic effects via activation of mitochondrial biogenesis pathways.

Reported mechanism

Pan-agonist of ERRα, ERRβ, and ERRγ — nuclear receptors that drive mitochondrial biogenesis gene programs typically activated by exercise. Published work in mouse models describes increased exercise capacity, improved metabolic profiles in obesity, and enhanced muscle oxidative phenotype following SLU-PP-332 administration.

Research context

An investigational research compound. Not FDA-approved and not in clinical trials as of publication. Generating interest as a potential "exercise mimetic" for research into metabolic disease models.

The above summarizes published research literature. This is not medical advice, a protocol, or a recommendation for use. This compound is supplied for laboratory research only.

03

Storage & release.

SHIP TEMP
Ambient
Lyophilized; stable at room temp in transit.
UNOPENED
Refrigerate
Lyophilized, protected from light.
RECONSTITUTED
~28 days
At 2–8°C; never freeze solutions.
RELEASE DOC
COA · per lot
3rd-party analytical · attached at ship.
lab@peptidebros:~$ cat release.slu-pp-332.SLU-26-Q1-0008.log
// lot release record
compound SLU-PP-332 (C21H27N3O3)
lot.id SLU-26-Q1-0008
class small molecule
mw.theoretical 369.5 Da
mw.observed 369.5 Da  [PASS]
purity.hplc 99.91%  [> 99.5% spec]
endotoxin < 0.125 EU/mL  [PASS]
sterility no growth  [PASS]
release.status RELEASED
04

Common questions.

What's the molecular profile?+

SLU-PP-332 is a small molecule (molecular formula C21H27N3O3, MW approximately 369.5 Da) — not a peptide.

The full structural data and release specifications are in the Compound Profile section above. Every lot ships with an independently verified Certificate of Analysis.

How is purity verified?+

Each lot is independently verified by a 3rd-party analytical laboratory (STERIS Labs, Alcami Analytical, or equivalent) before release. Release specification is HPLC purity ≥ 99.5% (typical > 99.8%), mass spectrometry identity match within ±0.5 Da, water content < 5.0% Karl Fischer, and endotoxin < 0.25 EU/mL by LAL (USP <85>).

Look up the full COA for your lot at coa-lookup.html.

How is the compound shipped and stored?+

All compounds ship at ambient temperature in discreet, tamper-evident packaging. Lyophilized peptide powder is stable at room temperature for typical transit windows, which is why research-grade vendors ship this way. Tracked; signature not required.

Store unopened lyophilized product at 2–8°C protected from light. Once reconstituted, most peptides are stable at 2–8°C for approximately 28 days (compound-dependent).

Is this compound FDA-approved?+

An investigational research compound. Not FDA-approved and not in clinical trials as of publication. Generating interest as a potential "exercise mimetic" for research into metabolic disease models.

All PeptideBros compounds are sold strictly as chemical reference materials for in-vitro laboratory research. They are not for human consumption.

Every lot,
on paper.

HPLC-verified. Mass-spec confirmed. Ambient-stable transit. The paperwork other vendors hope you never ask for.